ATE136553T1 - Methylpyrrolidonchitosan, verfahren zu dessen herstellung und seine verwendungen - Google Patents

Methylpyrrolidonchitosan, verfahren zu dessen herstellung und seine verwendungen

Info

Publication number
ATE136553T1
ATE136553T1 AT91920494T AT91920494T ATE136553T1 AT E136553 T1 ATE136553 T1 AT E136553T1 AT 91920494 T AT91920494 T AT 91920494T AT 91920494 T AT91920494 T AT 91920494T AT E136553 T1 ATE136553 T1 AT E136553T1
Authority
AT
Austria
Prior art keywords
pct
production
sec
formula
recurring units
Prior art date
Application number
AT91920494T
Other languages
English (en)
Inventor
Ricardo Muzzarelli
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Application granted granted Critical
Publication of ATE136553T1 publication Critical patent/ATE136553T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/736—Chitin; Chitosan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Polymers & Plastics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cosmetics (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pyrrole Compounds (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT91920494T 1990-11-26 1991-11-18 Methylpyrrolidonchitosan, verfahren zu dessen herstellung und seine verwendungen ATE136553T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT00064290A IT1243260B (it) 1990-11-26 1990-11-26 Metil pirrolidon chitosano, processo di produzione e suo uso.

Publications (1)

Publication Number Publication Date
ATE136553T1 true ATE136553T1 (de) 1996-04-15

Family

ID=11099998

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91920494T ATE136553T1 (de) 1990-11-26 1991-11-18 Methylpyrrolidonchitosan, verfahren zu dessen herstellung und seine verwendungen

Country Status (13)

Country Link
US (1) US5378472A (de)
EP (1) EP0512095B1 (de)
JP (1) JPH05503733A (de)
KR (1) KR927003132A (de)
AT (1) ATE136553T1 (de)
AU (1) AU639163B2 (de)
CA (1) CA2074517A1 (de)
CZ (1) CZ281052B6 (de)
DE (1) DE69118683T2 (de)
ES (1) ES2084838T3 (de)
HU (1) HUT62017A (de)
IT (1) IT1243260B (de)
WO (1) WO1992009635A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4320871C2 (de) * 1993-06-24 1995-05-04 Beiersdorf Ag Kosmetische und dermatologische Zubereitungen mit einem Gehalt an delta-Aminolävulinsäure
DE4446380A1 (de) * 1994-07-05 1996-01-11 Lohmann Therapie Syst Lts Hydrogel für die Applikation von therapeutischen und/oder kosmetischen Wirkstoffen an die Haut
US6486140B2 (en) 1994-07-19 2002-11-26 Medicarb Ab Agents, and methods employing them, for the prevention or reduction of tissue adhesion at a wound site
US5597811A (en) * 1995-04-10 1997-01-28 Amerchol Corporation Oxirane carboxylic acid derivatives of polyglucosamines
CA2224253A1 (en) * 1995-06-09 1996-12-27 Martin J. Macphee Chitin hydrogels, methods of their production and use
DE19643066C2 (de) * 1996-10-18 1999-07-01 Henkel Kgaa Kollagenfreie kosmetische Zubereitungen und Verfahren zu ihrer Herstellung
US5770712A (en) * 1997-03-14 1998-06-23 Virginia Tech Intellectual Properties, Inc. Crosslinked hydrogel beads from chitosan
KR19990000270A (ko) 1997-06-04 1999-01-15 박원훈 키토산으로 도포된 백혈구 제거용 필터
US6197322B1 (en) 1997-12-23 2001-03-06 Kimberly-Clark Worldwide, Inc. Antimicrobial structures
DE19804367C2 (de) * 1998-02-04 2001-11-22 Spiller Biocosmetic Gmbh Dr Mittel zur Entfernung einer kosmetischen Packung
IL132212A (en) * 1998-10-23 2003-03-12 Milliken & Co Textile fabric with particle attracting finish
US20030206958A1 (en) * 2000-12-22 2003-11-06 Cattaneo Maurizio V. Chitosan biopolymer for the topical delivery of active agents
US20060004314A1 (en) * 2001-06-14 2006-01-05 Hemcon, Inc. Antimicrobial barriers, systems, and methods formed from hydrophilic polymer structures such as chistosan
US8741335B2 (en) 2002-06-14 2014-06-03 Hemcon Medical Technologies, Inc. Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from hydrophilic polymer foam such as Chitosan
US7371403B2 (en) * 2002-06-14 2008-05-13 Providence Health System-Oregon Wound dressing and method for controlling severe, life-threatening bleeding
BR0210406A (pt) * 2001-06-14 2006-04-04 Providence Health Sys Oregon curativo de ferimento, e, métodos de controle de sangramento severo, e de produção de um curativo de ferimento capaz de controlar o sangramento severo
KR20030006788A (ko) * 2001-07-16 2003-01-23 이승진 치주질환 치료용 서방출성 고분자제제
US6926903B2 (en) * 2001-12-04 2005-08-09 Inion Ltd. Resorbable polymer composition, implant and method of making implant
US8269058B2 (en) * 2002-06-14 2012-09-18 Hemcon Medical Technologies, Inc. Absorbable tissue dressing assemblies, systems, and methods formed from hydrophilic polymer sponge structures such as chitosan
US20050137512A1 (en) * 2003-12-23 2005-06-23 Campbell Todd D. Wound dressing and method for controlling severe, life-threatening bleeding
EP1402905A1 (de) * 2002-09-24 2004-03-31 The Procter & Gamble Company Flüssigkeitsabsorbierende thermoplastische Zusammensetzung enthaltend Partikel aus superabsorbierendem Material mit im wesentlichen kantenfreier Gestalt
DE60223808T2 (de) * 2002-09-24 2008-10-30 The Procter & Gamble Company, Cincinnati Absorbierender Artikel mit einem aus einer saugfähigen thermoplastischen Zusammensetzung bestehendem Element
EP1440683A1 (de) * 2003-01-23 2004-07-28 Cognis France S.A. Verwendung von Oligoglucosaminen in kosmetischen oder dermatologischen Zubereitungen
ATE486664T1 (de) 2003-08-11 2010-11-15 Procter & Gamble Verfahren zum auftragen von klebstoff
EP1579831A1 (de) 2004-03-23 2005-09-28 The Procter & Gamble Company Absorbierender Artikel mit Seitenbarriere, die eine flüssigkeitsabsorbierende thermoplastische Zusammensetzung enthält
WO2006005211A1 (de) * 2004-07-12 2006-01-19 Gaba International Ag Mundpflegemittel enthaltend chitosanderivat
US9204957B2 (en) * 2005-03-17 2015-12-08 Hemcon Medical Technologies, Inc. Systems and methods for hemorrhage control and or tissue repair
EP1829561A1 (de) * 2006-03-03 2007-09-05 The Procter and Gamble Company Thermoplastische Absorbtionsmaterialen für proteinhaltige oder seröse Körperflüssigkeiten
JP2009538192A (ja) 2006-05-23 2009-11-05 プロビデンス ヘルス システム−オレゴン ディー／ビー／エー プロビデンス セント ビンセント メディカル センター 体の内腔または体の中空器官内に包帯構造を導入および適用するシステムおよび方法
US8932560B2 (en) * 2007-09-04 2015-01-13 University of Maryland, College Parke Advanced functional biocompatible polymeric matrix used as a hemostatic agent and system for damaged tissues and cells
AU2009241687A1 (en) * 2008-05-02 2009-11-05 Providence Health System-Oregon D/B/A Providence St. Vincent Medical Center Wound dressing devices and methods
EP2340002B1 (de) 2008-10-06 2015-03-25 Providence Health System - Oregon Medizinische schaumvorrichtungen und verfahren
CN106913902A (zh) 2009-11-09 2017-07-04 聚光灯技术合伙有限责任公司 多糖基水凝胶
CN102695501A (zh) 2009-11-09 2012-09-26 聚光灯技术合伙有限责任公司 碎裂水凝胶

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61253065A (ja) * 1985-05-02 1986-11-10 片倉チツカリン株式会社 キトサン誘導体およびコラ−ゲンの複合材の医用材料およびその製造法
IT1190380B (it) * 1985-06-21 1988-02-16 Consiglio Nazionale Ricerche Glucani funzionalizzati e reticolati,procedimento e intermedi di preparazione,loro usi

Also Published As

Publication number Publication date
IT9000642A0 (it) 1990-11-26
EP0512095B1 (de) 1996-04-10
EP0512095A1 (de) 1992-11-11
HU9202434D0 (en) 1992-10-28
CZ230592A3 (en) 1993-02-17
IT9000642A1 (it) 1992-05-27
CA2074517A1 (en) 1992-05-27
AU8956691A (en) 1992-06-25
HUT62017A (en) 1993-03-29
CZ281052B6 (cs) 1996-06-12
WO1992009635A1 (en) 1992-06-11
US5378472A (en) 1995-01-03
ES2084838T3 (es) 1996-05-16
JPH05503733A (ja) 1993-06-17
AU639163B2 (en) 1993-07-15
DE69118683T2 (de) 1996-08-29
KR927003132A (ko) 1992-12-17
DE69118683D1 (de) 1996-05-15
IT1243260B (it) 1994-05-26

Similar Documents

Publication Publication Date Title
ATE136553T1 (de) Methylpyrrolidonchitosan, verfahren zu dessen herstellung und seine verwendungen
TR27835A (tr) Sübstitüe edilmis azadiokzasikloalkenler.
DE59510246D1 (de) Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
ATE204162T1 (de) Verfahren zur herstellung von wirkstoffzubereitungen in form einer festen lösung des wirkstoffs in einer polymermatrix
DE69225970D1 (de) Substituierte 2-phenyl-3-methocypropensäurenester als fungizide mittel.
IT1276071B1 (it) Compositi ad attivita' anti-infiammatoria
BR9607516A (pt) Processo para o revestimento de objetos com ácido hialuronico derivados dos mesmos e polimeros semi-sintéticos
EP0675708A1 (de) Pharmazeutische und dermokosmetische mittel enthaltend pferdecolostrum.
DE69429078D1 (de) Pharmacologisch wirksame pyridinderivate und verfahren zu deren herstellung
DE59409794D1 (de) Benzoylguanidine, ihre herstellung und ihre verwendung in arzneimitteln
ATE148610T1 (de) Antimikrobielle mittel sowie substituierte 2- cyclohexan-1-yl-amin-derivate und deren herstellung
BG103399A (en) New heterocycle-substituted benzamides and their application for the treatment of diseases
DE69101914D1 (de) Verzweigte fructo-oligosacchariden, verfahren zu ihrer herstellung und verwendung von diese enthaltenden mitteln.
DE59510042D1 (de) 2,2-dichloralkancarbonsäuren, verfahren zu ihrer herstellung diese enthaltende arzneimittel, und ihre verwendung zur behandlung der insulinresistenz
DK542288A (da) Kosmetisk middel paa basis af n-hydroxypropylisopropylether-chitosaner samt n-hydroxypropylisopropyletherderivater af chitosan
IL118167A0 (en) Pyrazolo (1,5a) pyrimidines their preparation and use
DE69311541D1 (de) Kosmetische oder pharmazeutische zusammensetzungen zur topischen anwendung die deacylierten glycerophospholipide enthalten
TW238305B (de)
ATE119539T1 (de) 99m-tc-cyclopentadienylcarbonyl -komplexe, verfahren zu ihrer herstellung sowie ihre verwendung in der diagnostik.
DK0751941T3 (da) Kemiske mellemprodukter, som kan anvendes i landbruget
DE69104842D1 (de) Zwischenprodukte für chelatbildende wirkstoffe mit vorherbestimmter symmetrie und verfahren zu ihrer herstellung.
ATE163402T1 (de) Substituierte ortho- ethenylphenylessigsäurederivate
DE59607683D1 (de) Neue borneolderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
ATE198887T1 (de) Substituierte arylthioalkylthiopyridine
HUT76271A (en) Substituted aminoalkylaminopyridines, process for producing them and their use

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee